申请人:SMITHKLINE BEECHAM PLC
公开号:EP1452534A1
公开(公告)日:2004-09-01
Derivatives of pleuromutilin in which the glycolic ester moiety at position 14 is replaced by R2(CH2)mX(CH2)nCH2COO are of use in antimicrobial therapy.
在14号位取代
甘醇酸酯基团的白残杆菌素衍
生物,其取代基为R2(
CH2)mX( )n COO,可用于抗微
生物治疗。